Teva mulling sale of Medis, respiratory assets
Israeli pharmaceutical company Teva is considering the sale of its Iceland-based unit Medis as well as some its respiratory treatment assets, Bloomberg reports. Medis develops generic medications for other companies and...To view the full article, register now.
Already a subscriber? Click here to view full article